Valuation: Safe Fertility Group

Market Cap 1.69B 50.12M 44.11M 40.99M 37.6M 70.6M 4.84B 71.77M 487M 191M 2.37B 188M 184M 8.31B P/E 2026 *
11.3x
P/E 2027 * 10.8x
Enterprise Value 1.69B 50.12M 44.11M 40.99M 37.6M 70.6M 4.84B 71.77M 487M 191M 2.37B 188M 184M 8.31B EV / Sales 2026 *
2.27x
EV / Sales 2027 * 2.09x
Free-Float
23.1%
Yield 2026 *
7.75%
Yield 2027 * 7.93%
05-08 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-21 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-19 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 22, 2026 CI
11-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
07/08/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
07/05/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
30/04/25 Safe Fertility Group Public Company Limited Approves Dividend for the Year 2024, Payable on 23 May 2025 CI
20/02/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
20/02/25 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 23, 2025 CI
07/11/24 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
02/11/24 125,378,468 Ordinary Shares of Safe Fertility Group Public Company Limited are subject to a Lock-Up Agreement Ending on 2-NOV-2024. CI
07/08/24 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
02/05/24 41,792,822 Ordinary Shares of Safe Fertility Group Public Company Limited are subject to a Lock-Up Agreement Ending on 2-MAY-2024. CI
1 week-3.48%
Current month-2.63%
1 month-0.89%
3 months-9.02%
6 months-5.93%
Current year-12.60%
1 week 5.5
Extreme 5.5
5.8
1 month 5.5
Extreme 5.5
5.85
Current year 5.5
Extreme 5.5
6.9
1 year 5.5
Extreme 5.5
7.95
3 years 5.5
Extreme 5.5
23.7
5 years 5.5
Extreme 5.5
23.7
10 years 5.5
Extreme 5.5
23.7
Manager TitleAgeSince
Chief Executive Officer 60 01/01/2007
Director of Finance/CFO 45 -
Chief Operating Officer 59 20/07/2009
Director TitleAgeSince
Director/Board Member 59 18/11/2019
Chairman 67 18/11/2019
Director/Board Member 54 -
Date Insider Type Main position Quantity % Market Cap.
20/1/26 Buy

Chief Executive Officer

10,000 0.0033%
19/1/26 Buy

Chief Executive Officer

62,000 0.0204%
12/1/26 Buy

Chief Executive Officer

27,500 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.48%-26.49% - 49.87M
+0.80%+1.16%+74.20%+43.56% 136B
+1.51%-0.92%+8.19%+34.04% 83.52B
+2.22%+4.71%+4.56%+53.85% 27.44B
-0.02%+8.81%+33.66%+57.83% 25.23B
+1.32%0.00%-14.98%-28.49% 20.05B
+17.17%+17.07%+47.31%+203.76% 17.14B
-0.86%-6.71%+2.39%-7.05% 14.55B
+0.50%+0.61%+55.59%+129.07% 15.04B
+0.65%+2.90%-5.83%-11.44% 12.98B
Average +2.33%+0.19%+17.86%+52.79% 35.24B
Weighted average by Cap. +1.76%+0.23%+37.12%+46.35%

Financials

2026 *2027 *
Net sales 744M 22.1M 19.46M 18.08M 16.58M 31.14M 2.13B 31.65M 215M 84.2M 1.05B 82.97M 81.18M 3.66B 808M 24.02M 21.14M 19.64M 18.02M 33.84M 2.32B 34.4M 234M 91.49M 1.14B 90.16M 88.22M 3.98B
Net income 148M 4.4M 3.87M 3.6M 3.3M 6.19M 425M 6.3M 42.75M 16.75M 208M 16.51M 16.15M 729M 156M 4.65M 4.09M 3.8M 3.49M 6.55M 449M 6.66M 45.21M 17.71M 220M 17.45M 17.08M 771M
Net Debt - -
Logo Safe Fertility Group
Safe Fertility Group Public Company Limited is a Thailand-based company engaged in providing an obstetrics and gynecology hospital. It is also engaged in the business of medical laboratory and cosmetic dermatology. The Company's segments are Obstetrics and Gynecology Hospital and Medical Laboratory, and Cosmetic Dermatology. Its services categories include In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI), Intrauterine Insemination (IUI), Egg Freezing, Embryo Transfer, Sperm Freezing, Sperm Analysis, Magnetic Activated Cell Sorting (MACS) Sperm, Intracytoplasmic Morphologically Selected Sperm Injection (IMSI), Testicular Sperm Extraction/Percutaneous Epididymal Sperm Aspiration (TESE/PESA), Couple Check-Up, EmbryoScope Plus, Preimplantation Genetic Testing for Aneuploidy (PGT-A), Preimplantation Genetic Testing for Monogenic Disorders (PGT-M), and Acupuncture. The Company's subsidiaries include Next Generation Genomics Co., Ltd., and Safe Wellness Company Limited.
Employees
-
Date Price Change Volume
24/07/26 THB 5.550 0.00% 112,113
23/07/26 THB 5.550 -0.89% 404,988
22/07/26 THB 5.600 -1.75% 180,100
21/07/26 THB 5.700 -0.87% 87,110
20/07/26 THB 5.750 0.00% 78,000
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.550THB
Average target price
8.475THB
Spread / Average Target
+52.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SAFE Stock